BIAFVSPRME• 28 Days (Normalized)
BIAF vs PRME (bioAffinity Technologies Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BIAF Performance $6.36
-10.36%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
PRME Performance $3.14
+2.95%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin PRME LEADS
-13.31%
PRME outperforming by 13.31%
BIAFPRME
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BIAF PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BIAF Price | BIAF Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $6.36 | -10.36% | $3.14 | +2.95% | -13.31% |
| Sep 14, 2026 | $7.93 | +11.77% | $3.18 | +4.26% | +7.51% |
| Sep 11, 2026 | $7.95 | +12.05% | $3.13 | +2.62% | +9.43% |
| Sep 10, 2026 | $9.39 | +32.35% | $3.35 | +9.84% | +22.51% |
| Sep 09, 2026 | $10.50 | +47.99% | $3.47 | +13.77% | +34.22% |
| Sep 08, 2026 | $8.93 | +25.86% | $3.56 | +16.72% | +9.14% |
| Sep 04, 2026 | $15.27 | +115.22% | $3.70 | +21.31% | +93.91% |
| Sep 03, 2026 | $12.78 | +80.13% | $3.71 | +21.64% | +58.49% |
| Sep 02, 2026 | $9.75 | +37.42% | $3.67 | +20.33% | +17.09% |
| Sep 01, 2026 | $6.59 | -7.12% | $3.57 | +17.05% | -24.17% |
| Aug 31, 2026 | $4.56 | -35.73% | $3.59 | +17.70% | -53.43% |
| Aug 28, 2026 | $4.87 | -31.36% | $3.61 | +18.36% | -49.72% |
| Aug 27, 2026 | $5.06 | -28.68% | $3.64 | +19.34% | -48.02% |
| Aug 26, 2026 | $5.09 | -28.26% | $3.58 | +17.38% | -45.64% |
| Aug 25, 2026 | $5.19 | -26.85% | $3.71 | +21.64% | -48.49% |
Page 1 of 2